Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats

Journal of Hypertension

Volumn 26, Issue 8, 2008, Pages 1595-1601

  Rizzoni, Damiano ^a,d   Pasini, Evasio ^b   Flati, Vincenzo ^c   Rodella, Luigi F ^d   Paiardi, Silvia ^a   Assanelli, Deodato ^a   De Ciuceis, Carolina ^a   Porteri, Enzo ^a   Boari, Gianluca Em ^a   Rezzani, Rita ^d   Speca, Silvia ^c   Favero, Gaia ^d   Martinotti, Stefano ^e   Toniato, Elena ^e   Platto, Caterina ^a   Agabiti Rosei, Enrico ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

Angiotensin receptor blockers; Angiotensin converting enzyme inhibitors; Enalapril; Hypertension; Insulin; Microcirculation; Olmesartan; Small vessels

Indexed keywords

ENALAPRIL; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; OLMESARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAZOLE DERIVATIVE; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SLC2A4 PROTEIN, RAT; TETRAZOLE DERIVATIVE; TORC1 PROTEIN, RAT; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; ESSENTIAL HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MICROANGIOPATHY; MICROVASCULAR RAREFACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUADRICEPS FEMORIS MUSCLE; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; WESTERN BLOTTING; ANIMAL; CAPILLARY; HEART MUSCLE; HYPERTENSION; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULARIZATION; WISTAR KYOTO RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPILLARIES; ENALAPRIL; GLUCOSE TRANSPORTER TYPE 4; HYPERTENSION; IMIDAZOLES; INSULIN; INSULIN RESISTANCE; MALE; MYOCARDIUM; QUADRICEPS MUSCLE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, INSULIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; TETRAZOLES; TRANSCRIPTION FACTORS;

EID: 51549101894     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328304b060     Document Type: Article

References (26)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
2. Reaven GM. Insulin resistance, hyperinsulinemia and hypertriglyceridemia in the etiology and the clinical course of hypertension. Am J Med 1991; 90:7S-12S.
3. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skelet al muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension 1993; 21:129-135.
4. Bhanot S, McNeill JH. Insulin and hypertension: a causal relationship? Cardiovasc Res 1996; 31:212-221.
5. Modan M, Halkin H, Almog S, Lusky A, Eskol A, Shefi M. Hyperinsulinemia. A link between hypertension, obesity, and glucose intolerance. J Clin Invest 1985; 75:809-817.
6. Capaldo B, Lembo G, Napoli R, Rendina V, Albano G, Sacca L. Skelet al muscle is a primary site of insulin resistance in essential hypertension. Metab Clin Exp 1991; 40:1320-1322.
7. Natali N, Santoro D, Palombo C, Cerri M, Ghione S, Ferrannini E. Impaired insulin action on skelet al muscle metabolism in essential hypertension. Hypertension 1991; 17:170-178.
8. Nuutila P, Maki M, Laine H, Knuuti MJ, Ruotsalainen U, Luotolahti M. Insulin action on heart and skelet al muscle glucose uptake in essential hypertension. J Clin Invest 1995; 96:1003-1009.
9. Morisco C, Condorelli G, Orzi F, Vigliotta G, Di Grezia R, Beguinot F, et al. Insulin-stimulated cardiac glucose uptake is impaired in spontaneously hypertensive rats: role of early steps of insulin signaling. J Hypertens 2006;24:1607-1617.
10. Shimamoto K, Ura N. Mechanisms ofinsulin resistance in hypertensive rats. Clin Exp Hypertens 2006; 28:543-552.
11. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007; 369:201-207.
12. Munoz MC, Argentino DP, Dominaci FP, Turyn D, Toblli JE. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. J Hypertens 2006; 24:1607-1617.
13. Kimball SR, Siegfried BA, Jefferson LS. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP- activated protein kinase. J Biol Chem 2004; 279:54103-54109.
14. Mancia G, Grassi G, Zanchetti A. New-onsetdiabetes and antihypertensive drugs. J Hypertens 2006; 24:3-10.
15. Jandeleit-Dahm KAM, Tikellis C, Reid CM, Johnston CI, Cooper ME. Why blockade of the renin -angiotensin system reduces the incidence of new- onset diabetes. J Hypertens 2005; 23:463-473.
16. Cooper ME, Tikellis C, Thomas MC. Preventing diabetes in patients with hypertension: one more reason to block the renin -angiotensin system. J Hypertens 2006; 24. (suppl 1):S57-S63.
17. Baritono E, Ceolotto G, Papparella I, Sartori M, Ciccariello L, Iori E, et al. Abnormal regulation of G protein æ2. subunit in skin fibroblasts from insulin-resistant hypertensive individuals. J Hypertens 2004; 22:783-792.
18. Al Jaroudi WA, Nuwayri-Salti N, Usta JA, Zwainy DS, Karam CN, Bitar KM, Bikhazi AB. Effect of insulin and angiotensin II receptor subtype-1. antagonist on myocardial remodelling in rats with insulin-dependent diabetes mellitus. J Hypertens 2005; 23:381-392.
19. Wolfe RR. The underappreciated role ofmuscle in health and disease. Am J Clin Nutr 2006; 84:475-482.
20. Agabiti Rosei E, Rizzoni D. The effects of hypertension on the structure of human resistance arteries. In: Lip GYH and Hall JE, editors. Comprehensive Hypertension. Mosby Elsevier 2007. pp. 579-590.
21. Struijker Boudier HAJ. Microcirculation in hypertension. Eur Heart J 1999; 1. (Suppl. L):L32-L37.
22. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HAJ. Microcirculation in hypertension. A new target for treatment? Circulation 2001; 104:735-740.
23. Henrich HA, Romen W, Heimgartner W, Hartung E, Baumer F. Capillary rarefaction characteristics of the skelet al muscle of hypertensive patients. Klin Wochenschr 1988; 66:54-60.
24. Levy BI, Delafosse JM, Duriez M, Poitevin P, Schiavi P, Guez D, Samuel JL. Effect of low doses of perindopril and indapmide alone or combination (Preterax) in renovascular hypertensive rats. Eur Heart J 1999; 1. (Suppl. L):L50-L57.
25. Rakusan K, Cicutti N, Maurin A, Guez D, Schiavi P. The effect of treatment with low-dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats. Microvasc Res 2000;59:243-254.
26. Munzenmaier DH, Greene AS. Chronic angiotensin II AT1. receptor blockade increases cerebral cortical microvessel density. Am J Physiol Heart Circ Physiol 2006; 290:H512-H516.